US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Tacrolimus 0.03% Oph Solution Tacrolimus 0.1%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0237-2023
Class II · Moderate risk Terminated

Semaglutide 0.5mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0236-2023
Class II · Moderate risk Terminated

Scopolamine Hydrobromide 0.25% Oph Solution

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0235-2023
Class II · Moderate risk Terminated

Prostaglandin

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0234-2023
Class II · Moderate risk Terminated

Progesterone-Gs Oil- 100mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0233-2023
Class II · Moderate risk Terminated

Polyhexamethylene Biguanide 0.2mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0232-2023
Class II · Moderate risk Terminated

Polidocanol 50mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0231-2023
Class II · Moderate risk Terminated

Phosphatidylcholine/Deoxycholic Acid

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0230-2023
Class II · Moderate risk Terminated

Phenol 10%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0229-2023
Class II · Moderate risk Terminated

Pe1/Papav/Phen 20mcg/30mg/2mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0228-2023
Class II · Moderate risk Terminated

Papaverine/Phentolamine 30mg/0.5mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0226-2023
Class II · Moderate risk Terminated

Nadh 10mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0225-2023
Class II · Moderate risk Terminated

Mitomycin 0.4mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0224-2023
Class II · Moderate risk Terminated

Mitomycin 0.2mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0223-2023
Class II · Moderate risk Terminated

Methylcobalamin 12.5mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0222-2023
Class II · Moderate risk Terminated

Methotrexate Intravitreal

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0221-2023
Class II · Moderate risk Terminated

Magnesium Chloride Hexahydrate-Pf- 200mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0219-2023
Class II · Moderate risk Terminated

Lidocaine-Pf- 5%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0218-2023
Class II · Moderate risk Terminated

Levemir-Sts- 100u/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0217-2023
Class II · Moderate risk Terminated

Ketamine 50mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0216-2023
Class II · Moderate risk Terminated

Hydroxocobalamin-Pf- 1mg/Ml

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0215-2023
Class II · Moderate risk Terminated

Glycerin/Lidocaine Hcl/Epinephrine 31%

Reason Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Pharmacy Innovations D-0213-2023